Page 6 - Murrays Kessler News Today

/PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) ("Perrigo" or the "Company"), a leading provider of Quality, Affordable Self-Care Products, today...

The firm was hit with a revised tax bill by the Revenue in 2018 over a transaction with rival pharma company Biogen.

/PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from...

/PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that that President and CEO, Murray S. Kessler and CFO, Ray Silcock are scheduled to...

Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations Consumer Transformation Nearing Completion Ahead of Schedule Rx Transaction On-Track to Close in Q321; Rx Segment Now Reported in Discontinued Operations 2021 Guidance Reaffirmed Share this article Share this article DUBLIN, May 11, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from continuing operations for...

Hello and welcome to the Perrigo First Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference over to Bradley Joseph. Mr. Joseph, please go ahead. Bradley Joseph -- Vice President, Global Investor Relations and Corporate Communications Thank you and good morning, everybody, and welcome to Perrigos first quarter fiscal 2021 earnings conference call. I hope you all had a chance to review the press release we issued earlier this morning. A ...

Share this article Share this article DUBLIN, March 1, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 millio...

Perrigo sells generics division for $1.55b to Altaris Perrigo will now have no activities in Israel. The sale threatens 850 jobs in the Negev and the company might delist from the TASE. Perrigo Company (NYSE:PRGO; TASE:PRGO) announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners LLC for $1.55 billion, including $1.5 billion in cash. As part of the consideration, Altaris will also assume more than $50 million in pote...

Perrigo Company Plc (NYSE: PRGO) has agreed to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners for $1.55 ...

With more than 700 exhibitors and 50 sessions, revamped event will be held Feb. 1-5 Pivoting from its annual in-person event and conference, the Private Label Manufacturers Association (PLMA) will kick off its first major online event for store brands in the U.S. on Monday, Feb. 1, for five days of back-to-back presentations and a virtual exhibit floor featuring more than 700 manufacturers. “PLMA Live! presents Private Label Week” will be streaming a daily schedule of original on-dema...